Form 4: Director Arthur Higgins Increases ZBH Phantom Stock

Zimmer Biomet Holdings Director Arthur J. Higgins acquired 308.711 phantom stock units under the company's deferred compensation plan.

Summary

• Director Arthur J. Higgins acquired 308.711 phantom stock units on March 31, 2026.
• The units were acquired under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion price for these units is 1-for-1.
• Following this transaction, the reporting person holds a total of 36,375.195 phantom stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, having no material impact on the company's financial outlook.

Positives

• Director demonstrates continued alignment with company performance through participation in the deferred compensation plan.

Risks

• Phantom stock units are subject to the financial performance and creditworthiness of the issuer as they are settled in cash upon cessation of service.

Future Outlook

The units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the director's service ceases.

Management Comments

• The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Industry Context

StockSavvy.ai notes that director participation in deferred compensation plans is a standard corporate governance practice, signaling long-term commitment to the firm's equity performance without immediate cash outlay.

Comparison to Industry Standards

• The use of phantom stock plans for non-employee directors is consistent with compensation structures at large-cap medical device companies like Stryker or Medtronic.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Settlement of units in cash upon the director's eventual retirement or cessation of service.

Key Dates

Keywords

Zimmer Biomet, ZBH, Form 4, Insider Trading, Director Compensation, Phantom Stock